Credit Suisse’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-18,869
| Closed | -$86K | – | 4322 |
|
|
2019
Q1 | $86K | Buy |
18,869
+3,626
| +24% | +$17.2K | ﹤0.01% | 3864 |
|
|
2018
Q4 | $53K | Buy |
15,243
+2,625
| +21% | +$18.2K | ﹤0.01% | 3796 |
|
|
2018
Q3 | $127K | Sell |
12,618
-7,150
| -36% | -$57K | ﹤0.01% | 3706 |
|
|
2018
Q2 | $143K | Sell |
19,768
-692
| -3% | -$4.83K | ﹤0.01% | 3803 |
|
|
2018
Q1 | $124K | Sell |
20,460
-61,468
| -75% | -$508K | ﹤0.01% | 3773 |
|
|
2017
Q4 | $790K | Buy |
81,928
+48,717
| +147% | +$319K | ﹤0.01% | 3161 |
|
|
2017
Q3 | $295K | Buy |
33,211
+12,087
| +57% | +$125K | ﹤0.01% | 3754 |
|
|
2017
Q2 | $267K | Sell |
21,124
-9,879
| -32% | -$117K | ﹤0.01% | 3525 |
|
|
2017
Q1 | $326K | Buy |
31,003
+2,362
| +8% | +$25.2K | ﹤0.01% | 3492 |
|
|
2016
Q4 | $264K | Sell |
28,641
-12,983
| -31% | -$147K | ﹤0.01% | 3713 |
|
|
2016
Q3 | $491K | Sell |
41,624
-15,184
| -27% | -$231K | ﹤0.01% | 3434 |
|
|
2016
Q2 | $735K | Sell |
56,808
-25,339
| -31% | -$369K | ﹤0.01% | 3176 |
|
|
2016
Q1 | $1.31M | Buy |
82,147
+33,331
| +68% | +$633K | ﹤0.01% | 2524 |
|
|
2015
Q4 | $1.4M | Buy |
48,816
+4,696
| +11% | +$130K | ﹤0.01% | 2550 |
|
|
2015
Q3 | $1.26M | Sell |
44,120
-80,119
| -64% | -$2.95M | ﹤0.01% | 2621 |
|
|
2015
Q2 | $4.46M | Buy |
124,239
+59,371
| +92% | +$1.85M | ﹤0.01% | 1848 |
|
|
2015
Q1 | $1.89M | Sell |
64,868
-40,952
| -39% | -$1.08M | ﹤0.01% | 2439 |
|
|
2014
Q4 | $2.23M | Sell |
105,820
-46,524
| -31% | -$920K | ﹤0.01% | 2454 |
|
|
2014
Q3 | $2.95M | Buy |
152,344
+120,822
| +383% | +$1.9M | ﹤0.01% | 2182 |
|
|
2014
Q2 | $493K | Sell |
31,522
-28,714
| -48% | -$464K | ﹤0.01% | 3833 |
|
|
2014
Q1 | $1.25M | Buy |
60,236
+2,396
| +4% | +$47.5K | ﹤0.01% | 2921 |
|
|
2013
Q4 | $747K | Buy |
57,840
+9,165
| +19% | +$127K | ﹤0.01% | 3500 |
|
|
2013
Q3 | $568K | Buy |
+48,675
| New | +$400K | ﹤0.01% | 3420 |
|
Other funds holding INSY
WS
Credit Suisse's INSY Position: Q2 2019 in Review
Credit Suisse sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 18,869 shares — an estimated $86K sold.
Credit Suisse first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $4.46M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Credit Suisse reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Credit Suisse sold 18,869 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $86K.
- Credit Suisse first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- Credit Suisse's Insys Therapeutics, Inc. position peaked at $4.46M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.